Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Capello Jeffrey D
Relationship:   EVP & Chief Financial ...
City:   Wellesley
State:   MA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   106,104    

Indirect Shares

   0      
Direct Value   $9,976,691    

Indirect Value

   $0      
Total Shares   106,104      
Total Value   $9,976,691      


Perkinelmer Inc $9,280,856 Boston Scientific Corp $32,707 Tempest Therapeutics, Inc $11,778 Biogen Idec Inc $651,350 Perkinelmer Inc $9,280,856 Boston Scientific Corp $32,707 Tempest Therapeutics, Inc $11,778 Biogen Idec Inc $651,350
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Perkinelmer Inc PKI SVP & CFO 2008-01-29 91,428 2004-01-27 0    Premium*  
            Boston Scientific Corp BSX EVP & Chief Financial ... 2013-11-27 447 2009-06-16 0    Premium*  
            Tempest Therapeutics, Inc TPST Director 2013-03-18 11,111 2013-03-18 0    Premium*  
            Biogen Idec Inc BIIB EVP & Chief Financial ... 2020-02-12 3,118 2019-01-02 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BIIB Biogen Idec Inc EVP & Chief Financial Officer   •       •      –    2020-02-12 4 D $331.76 $203,701 D/D (614) 3,118 0 -
BIIB Biogen Idec Inc EVP & Chief Financial Officer   •       •      –    2020-02-12 4 OE $0.00 $0 D/D 1,919 3,732 0 -
BIIB Biogen Idec Inc EVP & Chief Financial Officer   •       •      –    2020-01-02 4 D $294.20 $119,445 D/D (406) 1,813 0 -
BIIB Biogen Idec Inc EVP & Chief Financial Officer   •       •      –    2020-01-02 4 OE $0.00 $0 D/D 1,302 2,219 0 -
BIIB Biogen Idec Inc EVP & Chief Financial Officer   •       •      –    2019-01-02 4 OE $0.00 $0 D/D 1,331 1,331 0 -
BIIB Biogen Idec Inc EVP & Chief Financial Officer   •       •      –    2019-01-02 4 D $304.69 $126,142 D/D (414) 917 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-11-27 4 S $11.70 $1,270,583 D/D (108,595) 447 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-11-26 4 OE $6.28 $296,129 D/D 46,701 194,148 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-11-26 4 S $11.82 $1,005,698 D/D (85,106) 109,042 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-11-25 4 OE $6.91 $1,780,911 D/D 242,504 389,951 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-11-25 4 S $12.02 $2,915,068 D/D (242,504) 147,447 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-11-22 4 S $12.02 $1,803,090 D/D (150,000) 147,447 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-11-22 4 OE $7.41 $1,217,468 D/D 150,000 297,447 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       –      –    2013-08-29 4 S $10.67 $5,607,309 D/D (525,000) 147,447 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       –      –    2013-08-29 4 OE $7.41 $3,519,750 D/D 475,000 535,909 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-06-16 4 D $9.51 $59,980 D/D (6,307) 197,447 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-06-16 4 OE $0.00 $0 D/D 14,665 203,754 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-05-12 4 OE $0.00 $0 D/D 7,235 191,448 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-05-12 4 D $8.45 $19,934 D/D (2,359) 189,089 0 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2013-03-18 4 B $9.00 $99,999 D/D 11,111 11,111 2.39 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-02-28 4 D $7.39 $25,237 D/D (3,415) 184,213 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-02-28 4 OE $0.00 $0 D/D 10,474 187,628 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-02-27 4 D $7.33 $43,760 D/D (5,970) 177,154 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-02-27 4 OE $0.00 $0 D/D 18,312 183,124 0 -
BSX Boston Scientific Corp EVP & Chief Financial Officer   •       •      –    2013-02-24 4 OE $0.00 $0 D/D 3,012 165,794 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us